Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LIZA C VILLARUZ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1609060755
CMS profile
72179
Location
PITTSBURGH, PA

General Payments · PY2018–2024

$53,002.68

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$10,870.97

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $6,433.72 8
PY2019 $5,758.52 5
PY2020 $1,240.00 1
PY2021 $14,196.51 9
PY2022 $7,152.96 9
PY2023 $7,350.00 4
PY2024 $10,870.97 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $107.09 02/23/2024 Food and Beverage Undisputed 01/23/2026 1105512349 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1105885817 CMS
AstraZeneca Pharmaceuticals LP $135.00 06/03/2024 Food and Beverage Undisputed 01/23/2026 1104564094 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 1104306650 CMS
AstraZeneca Pharmaceuticals LP $2,397.50 08/01/2024 Consulting Fee Undisputed 01/23/2026 1105271689 CMS
AstraZeneca Pharmaceuticals LP $1,875.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1104197819 CMS
Boehringer Ingelheim International GmbH $170.69 07/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118076488 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3.85 12/17/2024 Food and Beverage Undisputed 01/23/2026 1118076484 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.48 12/17/2024 Food and Beverage Undisputed 01/23/2026 1118076486 CMS
Daiichi Sankyo Inc. $1,935.00 02/21/2024 Consulting Fee Undisputed 01/23/2026 1089495176 CMS
Janssen Biotech, Inc. $108.34 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078590642 CMS
Janssen Scientific Affairs, LLC $1,350.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1078858134 CMS
Regeneron Healthcare Solutions, Inc. $17.02 07/29/2024 Education Undisputed 01/23/2026 1114238084 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.